{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:13:11Z","timestamp":1776910391949,"version":"3.51.2"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10072-020-04522-2","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T13:02:15Z","timestamp":1592658135000},"page":"1981-1983","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Coronavirus disease 2019: favorable outcome in an immunosuppressed patient with multiple sclerosis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9410-581X","authenticated-orcid":false,"given":"Jens","family":"Devogelaere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie B.","family":"D\u2019hooghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Famke","family":"Vanderhauwaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"D\u2019haeseleer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,20]]},"reference":[{"issue":"2","key":"4522_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1352458519858604","volume":"26","author":"BV Ineichen","year":"2020","unstructured":"Ineichen BV, Moridi T, Granberg T, Piehl F (2020) Rituximab treatment for multiple sclerosis. Mult Scler 26(2):137\u2013152","journal-title":"Mult Scler"},{"issue":"11","key":"4522_CR2","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"J Kurtzke","year":"1983","unstructured":"Kurtzke J (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444\u20131452","journal-title":"Neurology"},{"key":"4522_CR3","doi-asserted-by":"crossref","unstructured":"Rothan HA, Byrareddy SN (2020) The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 109:102433","DOI":"10.1016\/j.jaut.2020.102433"},{"key":"4522_CR4","doi-asserted-by":"crossref","unstructured":"Gao Y, Li T, Han M et al (2020) Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol 92(7):791\u2013796","DOI":"10.1002\/jmv.25770"},{"key":"4522_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jmv.25685","volume":"92","author":"G Li","year":"2020","unstructured":"Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J (2020) Coronavirus infections and immune responses. J Med Virol 92:424\u2013432","journal-title":"J Med Virol"},{"issue":"7\u20138","key":"4522_CR6","first-page":"370","volume":"73","author":"Q Maloir","year":"2018","unstructured":"Maloir Q, Ghysen K, von Frenckell C, Louis R, Guiot J (2018) Acute respiratory distress revealing antisynthetase syndrome. Rev Med Liege 73(7\u20138):370\u2013375","journal-title":"Rev Med Liege"},{"issue":"13","key":"4522_CR7","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1073\/pnas.1323279111","volume":"111","author":"Z Jincun","year":"2014","unstructured":"Jincun Z, Kun L, Christine WL et al (2014) Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A 111(13):4970\u20134975","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4522_CR8","doi-asserted-by":"crossref","unstructured":"Sarzi-Puttini P, Giorgi V, Sirotti S et al (2020) COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol 38(2):337\u2013342","DOI":"10.55563\/clinexprheumatol\/xcdary"},{"key":"4522_CR9","doi-asserted-by":"publisher","first-page":"102120","DOI":"10.1016\/j.msard.2020.102120","volume":"42","author":"G Novi","year":"2020","unstructured":"Novi G, Mikulska M, Briano F, Toscanini F, Tazza F, Uccelli A, Inglese M (2020) COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? Mult Scler Relat Disord 42:102120","journal-title":"Mult Scler Relat Disord"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04522-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04522-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04522-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T16:30:23Z","timestamp":1667061023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04522-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,20]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4522"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04522-2","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,20]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Jens Devogelaere reports no disclosures. Marie B. D\u2019hooghe received consultancy fees and travel support from Roche\u00ae. Famke Vanderhauwaert reports no disclosures. Miguel D\u2019haeseleer received consultancy fees and travel support from Roche\u00ae.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"None","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}